RankAlpha logo
Back to Rankings

MBIO

Mustang BioD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
Current thesis
The best bull read on the post-earnings setup is that MBIO has meaningfully reduced operating burn, exited a costly facility, ended Q1 with $16.3 million in cash, and still has a live clinical forward hook in a possible Q3 2026 MB-109 investigator-sponsored study. If management converts the leaner cost base into a longer runway without immediate heavy dilution, the stock could re-rate from distressed levels.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.3.
What can break
Fortress-related 2.5% financing share grants and annual 2.5% stock dividend mechanics create recurring dilution pressure.
Momentum
52
Value
55
Sentiment
30
Setup hits (3d)
— · Net —
AI TargetsBase $0.50 · Bull $0.90 · Bear $0.25
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-15 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net —
Target $10.00
Why
Momentum52 · Δ7d -
Value55 · Δ7d -0.3
Sentiment30 · Δ7d -
So what
Weak posture. Prioritize risk control and patience.
Setup hits not loaded

Load setup hits to see net bias and recent triggers.

Load setup hits
Lead driver: Value · See fundamentals
Momentum
52
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
55
39% active weight
Current posture
7d trendFlat
Δ7d
-0.3
Δ21d
-0.1
Sentiment
30
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade D. Momentum 51.8 / Value 55.4 / Sentiment 29.9

Fundamentals (TTM)
As of 2026-07-17
Market Cap
$4.76M
Beta
2.14
Shares Out
7.58M
P/E (TTM) · Derived
-1.6
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.74
Rev YoY
-100.0%
EPS YoY
+165.2%
Gross Margin
-
Op Margin
-
Net Debt
-$17.27M
Current Ratio
2.12
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology